Microscopic treatment of benign eyelid margin lesions with ultrapulse carbon dioxide (CO2) laser. (17th November 2021)

• Record Type: Journal Article
• Authors: Mao, Zhen; Lin, Bing-Ying; Huang, Yi-Dan; Huang, Dan-Ping
• Is Part Of: Journal of cosmetic and laser therapy. Volume 23:Number 7/8(2021)
• Page Start: 184
• Page End: 187
• Publication Date: 2021-11-17
• Subjects: Ultrapulse carbon dioxide laser -- laser surgery -- benign eyelid lesion -- eyelid margin; Skin -- Laser surgery -- Periodicals; Surgery, Plastic -- Periodicals; 617.477
• DOI: 10.1080/14764172.2022.2048673
• Languages: English
• ISSNs: 1476-4172

Abstract

ABSTRACT: Surgical treatment of eyelid margin lesions is challenging, and few studies focused on laser therapy of such type of lesions. To evaluate the safety and effectiveness of ultrapulse CO2 laser treatment under a microscope for benign eyelid margin lesions, we performed microscopic ultrapulse CO2 laser treatment win 132 patients with benign eyelid margin lesions for cosmetic reasons. Measurements included cosmetic results, complications and patients' satisfaction. Eighty lesions involved the gray line and 24 lesions were in the lacrimal region. All patients achieved satisfactory cosmetic and therapeutic outcomes. Eyelid contour recovered well with no scar and no malposition. No secondary epiphora was noted after the lesions adjacent to the lacrimal punctum were removed. At the end of follow-up, only 2 patients had mild hypopigmentation and only 1 patient required repeat laser therapy for recurrence. It turned out that ultrapulse CO2 laser treatment under a microscope is a dependable, safe, and effective method for the treatment of benign eyelid margin lesions. It is an excellent alternative to traditional surgery, especially for lesions involving the gray line or positioned in proximity to the lacrimal punctum. It is beneficial for simplifying the treatment, improving the cosmetic result, and maintaining eyelid function.